Craft

Minerva Surgical

Stock Price

$0

2024-10-29

Market Capitalization

$106.5 K

2024-10-29

Revenue

$50.3 M

FY, 2022

Minerva Surgical Summary

Company Summary

Overview
Minerva Surgical is a medical technology company that develops, manufactures, and commercializes surgical solutions for women’s healthcare. It offers Minerva ES and Genesys HTA, endometrial ablation systems, Symphion, an operative hysteroscopy system, and Resectr, a tissue resection device.
Type
Public
Status
Active
Founded
2008
HQ
Santa Clara, CA, US | view all locations
Website
https://minervasurgical.com/
Cybersecurity rating
Sectors

Key People

Operating MetricsView all

Products

4

FY, 2022

Trademark Applications

43

FY, 2022

Facility Space, sq. ft.

33K

FY, 2022

LocationsView all

1 location detected

  • Santa Clara, CA HQ

    United States

    4255 Burton Dr

Minerva Surgical Financials

Summary Financials

Revenue (Q3, 2023)
$12.0M
Gross profit (Q3, 2023)
$6.2M
Net income (Q3, 2023)
($7.2M)
Cash (Q3, 2023)
$11.1M
EBIT (Q3, 2023)
($6.1M)
Enterprise value
$32.5M

Footer menu